Coronavirus vaccine maker Moderna is pausing plans to build a manufacturing facility in Kenya.
It had planned to start filling doses of its Covid-19 vaccine on the continent as early as 2023, but Moderna says it has not received any vaccine orders for Africa since 2022.
The firm says there has been a decline in demand for Covid-19 vaccines, and that it is resizing its manufacturing network to cut costs.
Moderna is spending about $4.5bn (£3.6bn) this year in research and development of other, new vaccines including for HIV, malaria and cancer.
Profits are higher for cancer treatments, which require more doses per patient than coronavirus vaccines.
Source: BBC
Disclaimer: Opinions expressed here are those of the writers and do not reflect those of Peacefmonline.com. Peacefmonline.com accepts no responsibility legal or otherwise for their accuracy of content. Please report any inappropriate content to us, and we will evaluate it as a matter of priority. |